A Case of Sheehan Syndrome Presenting with Pancytopenia and Dilated Cardiomyopathy: A Rare Combination

    October 2022 in “ Journal of advanced research in medicine ”
    Malavika Prabhu
    Image of study
    TLDR A woman with Sheehan syndrome improved with hormone treatment.
    A 52-year-old female with symptoms of easy fatigability, asthenia, loss of appetite, alopecia, hypotension, hypoglycaemia, and a history of lactation failure and premature menopause was diagnosed with Sheehan syndrome, a rare condition following postpartum hemorrhage that leads to pituitary necrosis and panhypopituitarism. The patient's hormone profile indicated panhypopituitarism, and MRI showed a partially empty sella, while an echocardiogram revealed dilated cardiomyopathy with an ejection fraction of 35%. After starting treatment with injectable hydrocortisone and thyroid hormone supplementation, the patient showed improvement. This case highlights the importance of considering Sheehan syndrome in patients with similar presentations, as it is treatable with hormone replacement therapy.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community Low-Dose Oral Minoxidil Does Not Significantly Affect BP

      in Minoxidil  178 upvotes 2 months ago
      Low-dose oral minoxidil is used for hair loss and does not significantly affect blood pressure but may increase heart rate and cause hypotensive symptoms. Some users experience side effects like palpitations and shortness of breath, while others find it effective; topical minoxidil with tretinoin is also considered.
      [object Object]

      community 6 months of min 2x a day + .25mg fin 1x a day

      in Progress Pictures  252 upvotes 6 months ago
      A user shared progress pictures after 6 months of using minoxidil twice daily and 0.25mg finasteride once daily for hair loss. The conversation includes comments on the user's posture in the photos and slight improvements in hair fullness.

      community BREEZULA COVID UPDATE: Filing for Special Protocol Assessment with FDA

      in Research/Science  62 upvotes 4 years ago
      The conversation discusses the progress of Clascoterone (Breezula) for hair loss treatment, noting that COVID-19 delayed female trials by three months but Phase III trials for males are proceeding with a Special Protocol Assessment filed with the FDA. Users express hope for Breezula as an alternative to existing treatments like finasteride and minoxidil, despite concerns about its potential high cost.

      community Haircafe on why microneedling is bad for hair growth

      in Microneedling  159 upvotes 5 months ago
      Microneedling combined with minoxidil and finasteride shows significant hair regrowth, though opinions on its effectiveness vary. Some users report substantial benefits, while others highlight the need for more research and consistency in application.

    Similar Research

    5 / 1000+ results